[Disease-modifying drugs in pediatric patients with multiple sclerosis]. Bykova OV, Nankina IA, Drozdova IM, Kvasova OV, Batysheva TT, Boiko AN Zh Nevrol Psikhiatr Im S S Korsakova. 2016; 116(2. Vyp. 2. Rassejannyyj skleroz):44-53. PMID: 27070361. Abstract CommentRecommendBookmarkWatch